H3K4me3 remodeling induced acquired resistance through O-GlcNAc transferase
Drug Resistance Updates · 2023-11 · 71 · 100993
DOI: 10.1016/j.drup.2023.100993 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Resistance Updates, 2023-11. Verfasst von Dinoop Ravindran Menon und 19 weiteren Autor:innen. Beteiligte Einrichtung: Frazer Institute, The University of Queensland, Brisbane, QLD, Australia; Department of Dermatology, University of Colorado Denver, Aurora, CO, USA; …. Hauptthemen laut MEDLINE: Histones, AMP-Activated Protein Kinases. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: BLRD VA, NCI NIH HHS, VA.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Frazer Institute, The University of Queensland, Brisbane, QLD, Australia; Department of Dermatology, University of Colorado Denver, Aurora, CO, USA; Department of Medical Oncology, University of Colorado Denver, Aurora,…
- Frazer Institute, The University of Queensland, Brisbane, QLD, Australia; Department of Pharmaceutical Chemistry, The University of California, San Francisco, San Francisco, CA, USA.
- Department of Pathology, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand.
- Joanneum Research Forschungsgesellschaft m.b.H., HEALTH, Institute for Biomedicine and Health Sciences, Graz, Austria.
- Frazer Institute, The University of Queensland, Brisbane, QLD, Australia.
- Institute of Medical Biology, Agency for Science, Technology and Research, Immunos Singapore, Singapore.
Förderung
- BLRD VA
- NCI NIH HHS
- VA
Zitieren
APA
Ravindran Menon, D., Hammerlindl, H., Gimenez, G., Hammerlindl, S., Zuegner, E., Torrano, J., Bordag, N., Emran, A. A., Giam, M., Denil, S., Pavelka, N., Tan, A. C., Sturm, R. A., Haass, N. K., Rancati, G., Herlyn, M., Magnes, C., Eccles, M. R., Fujita, M., & Schaider, H. (2023). H3K4me3 remodeling induced acquired resistance through O-GlcNAc transferase. Drug Resistance Updates, 71, 100993. https://doi.org/10.1016/j.drup.2023.100993
Vancouver
Ravindran Menon D, Hammerlindl H, Gimenez G, Hammerlindl S, Zuegner E, Torrano J, et al. H3K4me3 remodeling induced acquired resistance through O-GlcNAc transferase. Drug Resistance Updates. 2023;71:100993. doi:10.1016/j.drup.2023.100993
BibTeX
@article{RavindranMenon2023,
author = {Ravindran Menon, Dinoop and Hammerlindl, Heinz and Gimenez, Gregory and Hammerlindl, Sabrina and Zuegner, Elmar and Torrano, Joachim and Bordag, Natalie and Emran, Abdullah Al and Giam, Maybelline and Denil, Simon and Pavelka, Norman and Tan, Aik-Choon and Sturm, Richard A and Haass, Nikolas K and Rancati, Giulia and Herlyn, Meenhard and Magnes, Christoph and Eccles, Michael R and Fujita, Mayumi and Schaider, Helmut},
title = {H3K4me3 remodeling induced acquired resistance through O-GlcNAc transferase},
journal = {Drug Resistance Updates},
year = {2023},
volume = {71},
pages = {100993},
doi = {10.1016/j.drup.2023.100993}
}
EUVIMED